Quality assessment of clinical practice guidelines for infectious diseases in China
Dongbo Wu
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorWei Jiang
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorLe Yu
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorYonghong Wang
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorYachao Tao
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorHong Tang
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorCorresponding Author
Enqiang Chen
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Correspondence
Enqiang Chen, Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, PR China.
Email: [email protected]
Search for more papers by this authorDongbo Wu
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorWei Jiang
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorLe Yu
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorYonghong Wang
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorYachao Tao
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorHong Tang
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Search for more papers by this authorCorresponding Author
Enqiang Chen
Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Correspondence
Enqiang Chen, Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, PR China.
Email: [email protected]
Search for more papers by this authorAbstract
Aim
We aimed to appraise the quality of Chinese Society of Infectious Diseases of China Medical Association clinical practice guidelines (CPGs) for infectious diseases in China.
Methods
We performed the electronic search and hand search on the above-mentioned CPGs for infectious diseases published from January 1997 to October 2017. Each publication was evaluated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument.
Results
Thirteen guidelines were identified and enrolled for the further evaluation. The median scores of the AGREE II domains across all 13 guidelines were as follows: scope and purpose 73.61% (36.11% to 84.72%), stakeholder involvement 12.50% (8.33% to 20.83%), rigor of development 19.27% (12.50% to 26.04%), clarity of presentation 86.11% (23.61% to 94.44%), applicability 33.33% (26.04% to 50.00%), and editorial independence 8.33% (4.17% to 16.67%). The clarity of presentation domain got the highest score among the six domains. Moreover, when compared the CPGs by the year of publication (2002 to 2006 vs. 2007 to 2017), the quality scores were higher in the CPGs published in the last 10 years than those published before, but with no significant difference.
Conclusions
The quality score of CPGs for infectious diseases in China from January 1997 to October 2017 was moderate, but had significant shortcomings, especially in the stakeholder involvement and editorial independence domains. However, the AGREE II instrument is useful and feasible for appraising the CPGs and should be applied to develop, implement, and promote the CPGs in China.
Supporting Information
| Filename | Description |
|---|---|
| jebm12293-sup-0001-SuppMat.docx204.4 KB | Online supplement table 1 Characteristics of AGREE Ⅱ instrument Online supplement table 2 Characteristics of included clinical practice guidelines Figure 1. Flowchart of included clinical practice guidelines. CPGs: clinical practice guidelines; CSI: Chinese Society of Infectious Disease of China Medical Association. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Yasar I, Kahveci R, Baydar AA, et al. Quality assessment of clinical practice guidelines developed by professional societies in Turkey. PLoS One. 2016; 11: e0156483.
- 2Sekercioglu N, Al-Khalifah R, Ewusie JE, et al. A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument. Int Urol Nephrol. 2017; 49: 273–284.
- 3Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011.
10.17226/13058 Google Scholar
- 4Brouwers MC, Kho ME, Browman GP, et al. AGREE II: Advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182: E839–E842.
- 5Sabharwal S, Patel NK, Gauher S, Holloway I, Athanasiou T. High methodologic quality but poor applicability: Assessment of the AAOS guidelines using the AGREE II instrument. Clin Orthop Relat Res. 2014; 472: 1982–1988.
- 6Jacobs C, Graham ID, Makarski J, et al. Clinical practice guidelines and consensus statements in oncology—an assessment of their methodological quality. PLoS One. 2014; 9: e110469.
- 7Zhang LL, Li YP, Zhang C, Huang L, Liang Y, Han L. Analysis on status of clinical guidelines and evaluation on evidence-based guidelines of children in China. Chin J Evid Based Med. 2011; 11: 991–999. [Article in Chinese]
- 8Zhang ZW, Liu XW, Xu BC, et al. Analysis of quality of clinical practice guidelines for otorhinolaryngology in China. PLoS One. 2013; 8: e53566.
- 9 AGREE Next Steps Consortium. The AGREE II Instrument (Electronic version). In: AGREE Enterprise Website, 2009. Available from: http://www.agreetrust.org (accessed 14 August 2013).
- 10 Chinese Society of Hepatology and Chinese Society of Infectious Diseases of Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B. Chin J Hepatol. 2005; 13: 881–891. [Article in Chinese]
- 11 Chinese Society of Hepatology and Chinese Society of Infectious Diseases of Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Infect Dis. 2011; 29: 65–80. [Article in Chinese]
- 12 Chinese Society of Hepatology and Chinese Society of Infectious Diseases of Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B: a 2015 update. Chin J Hepatol. 2015; 23: 888–905. [Article in Chinese]
- 13 Chinese Society of Hepatology and Chinese Society of Infectious Diseases of Chinese Medical Association. Guidelines on the prevention and treatment of hepatitis C. Chin J Hepatol. 2004; 12: 194–198. [Article in Chinese]
- 14 Chinese Society of Hepatology and Chinese Society of Infectious Diseases of Chinese Medical Association. The guideline of prevention and treatment for hepatitis C: a 2015 update. Chin J Hepatol. 2015; 23: 906–923. [Article in Chinese]
- 15 Chinese Society of Infectious Diseases of Chinese Medical Association. HIV/AIDS management guidelines. Chin J Infect Chemother. 2006; 6: 265–279. [Article in Chinese]
- 16 Chinese Society of Infectious Diseases of Chinese Medical Association. Guideline of diagnosis and treatment for AIDS. Chin J Infect Dis. 2011; 4: 321–330. [Article in Chinese]
- 17 Chinese Society of Infectious Diseases of Chinese Medical Association. Third edition of the guidelines for diagnosis and treatment of HIV/AIDS (2015). Chin J Infect Dis. 2015; 8: 385–401. [Article in Chinese]
- 18 Chinese Society of Infectious Diseases and Chinese Society of Hepatology of Chinese Medical Association. Diagnostic and treatment for liver failure. Chin J Hepatol. 2006; 14: 643–646. [Article in Chinese]
- 19 Chinese Society of Infectious Diseases and Chinese Society of Hepatology of Chinese Medical Association. Diagnostic and treatment guideline for liver failure (2012 version). Chin J Infect Dis. 2012; 5: 321–327. [Article in Chinese]
- 20 Chinese Society of Infectious Diseases of Chinese Medical Association. Guideline for indication, criterion and technology for the application of artificial liver. Chin J Infect Dis. 2002; 20: 254–258. [Article in Chinese]
- 21 Chinese Society of Infectious Diseases of Chinese Medical Association. Guideline for non-bioartificial liver support systems in treatment of liver failure: 2009 update. Chin J Infect Dis. 2009; 2: 321–325. [Article in Chinese]
- 22 Chinese Society of Infectious Diseases of Chinese Medical Association. Guideline for non-bioartificial liver support systems in treatment of liver failure: 2016 update. Chin J Infect Dis. 2016; 9: 97–103. [Article in Chinese]
- 23Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. J Evid Based Med. 2015; 8: 2–10.
- 24Chen Y, Hu S, Wu L, Fang X, Xu W, Shen G. Clinical practice guidelines for hypertension in China: A systematic review of the methodological quality. BMJ Open. 2015; 5: e008099.
- 25Chen YL, Yao L, Xiao XJ, et al. Quality assessment of clinical guidelines in China: 1993–2010. Chin Med J. 2012; 125: 3660–3664.
- 26Deng W, Li L, Wang Z, et al. Using AGREE II to evaluate the quality of traditional medicine clinical practice guidelines in China. J Evid Based Med. 2016. https://doi.org/10.1111/jebm.12197.
10.1111/jebm.12197 Google Scholar
- 27Hu J, Chen R, Wu S, et al. The quality of clinical practice guidelines in China: A systematic assessment. J Eval Clin Pract. 2013; 19: 961–967.
- 28Jiang M, Liao LY, Liu XQ, et al. Quality assessment of clinical practice guidelines for respiratory diseases in China: A systematic appraisal. Chest. 2015; 148: 759–766.
- 29Jiang Y, Zhu XD, Qu S, Li L, Zhou Z. Guidelines for squamous cell carcinoma of the head and neck: A systematic assessment of quality. Ear Nose Throat J. 2015; 94: E14–E24.
- 30Jin Y, Wang Y, Zhang Y, et al. Nursing practice guidelines in China do need reform: A critical appraisal using the AGREE II instrument. Worldviews Evid Based Nurs. 2016; 13: 124–138.
- 31Li CC, Wang YQ, Li YP, Li XL. Critical appraisal of clinical practice guidelines for treating pancreatic cancer based on the global disease burden. J Evid Based Med. 2015; 8: 11–21.
- 32Li J, Su K, Li F, et al. Systematic review of the methodology quality in lung cancer screening guidelines. Zhongguo Fei Ai Za Zhi. 2016; 19: 692–699. [Article in Chinese]
- 33Wang Y, Luo Q, Li Y, et al. Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer. PLoS One. 2014; 9: e103939.
- 34Yao L, Chen Y, Wang X, et al. Appraising the quality of clinical practice guidelines in traditional Chinese medicine using AGREE II instrument: A systematic review. Int J Clin Pract. 2017; 71. https://doi.org/10.1111/ijcp.12931.
- 35Yao S, Wei D, Chen YL, et al. Quality assessment of clinical practice guidelines for integrative medicine in China: A systematic review. Chin J Integr Med. 2017; 23: 381–385.
- 36Ye ZK, Liu Y, Cui XL, Liu LH. Critical appraisal of the quality of clinical practice guidelines for stress ulcer prophylaxis. PLoS One. 2016; 11: e0155020.
- 37Yu WY, Xu JL, Shi NN, et al. Assessing the quality of the first batch of evidence-based clinical practice guidelines in traditional Chinese medicine. J Tradit Chin Med. 2011; 31: 376–381.
- 38Zhang Z, Guo J, Su G, Li J, Wu H, Xie X. Evaluation of the quality of guidelines for myasthenia gravis with the AGREE II instrument. PLoS One. 2014; 9: e111796.
- 39Zheng ZH, Cui SQ, Lu XQ, et al. Analysis of the status of Chinese clinical practice guidelines development. BMC Health Serv Res. 2012; 12: 218.
- 40Zhi YJ, Liao X, Xie YM, et al. Methodological quality assessment of community-acquired pneumonia clinical practice guidelines in China based on AGREE tool. Zhongguo Zhong Yao Za Zhi. 2017; 42: 2175–2180. [Article in Chinese]
- 41Venkatesh AK, Savage D, Sandefur B, Bernard KR, Rothenberg C. Systematic review of emergency medicine clinical practice guidelines: Implications for research and policy. PLoS One. 2017; 12: e0178456.
- 42Wilby KJ, Black EK, MacLeod C, et al. Critical appraisal of clinical practice guidelines in pediatric infectious diseases. Int J Clin Pharm. 2015; 37: 799–807.
